Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
“This reflects continued growth of the company due to new business awards from our current pharmaceutical and biotechnology sponsors,” according to Timothy J. Schroeder, CTI CEO and President. “We are very fortunate to have long term relationships with these sponsors, in some cases for more than a decade, and they continue to partner with us. We are extremely grateful for the opportunities.”
CTI currently works with more than 60 pharmaceutical and biotechnology companies, including eight of the ten largest global companies. These office expansions will allow for expanded capabilities and additional personnel across all departments.